Accueil • Veille Scientifique • Ceftolozane-tazobactam Versus Meropenem for Treatment of Nosocomial Pneumonia (ASPECT-NP): A Randomised, Controlled, Double-Blind, Phase 3, Non-Inferiority Trial
Lancet Infect Dis • 2019.09.25
Kollef M.H., Nová?ek M., Kivistik Ü., et al.
- Clinical trial
- International
- Ceftolozane-tazobactam, Clinical trial, Drug therapy, Meropenem, Nosocomial Pneumonia